Niks Technology (543282)

Turnaround

Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Current Price₹494.85
Market Cap₹23.44 Cr
P/E Ratio72.5
ROCE12.16%
ROE0.37%
Dividend Yield0%
Profit Growth-53.57%
Debt/Equity
Sales Growth5.57%
52-Week Range₹413.25 — ₹494.85
SectorIT - Software
Book Value₹95.39

Strengths

Concerns

AI Analysis

Let's start with what we know: this is a ₹23 crore market-cap software consulting firm trading at ₹494.85, near its 52-week high. The first warning is price relative to value. The stock trades at 72.5 times trailing earnings and 5.19 times book value, while book value is only ₹95.39. But what are those earnings doing? They fell by 53.57% last year, and the latest quarter shows sales of ₹5 crore and net profit of essentially zero. That is not an earnings machine; that is an engine sputtering. Sales growth of 5.57% is modest and certainly cannot justify a PEG of 13.02. Return on equity is a dismal 0.37%, meaning for every rupee of equity, the business earns less than half a paisa after taxes. The 12.16% ROCE is better, but return on equity is what ultimately accrues to shareholders. There is no dividend, so minority shareholders depend entirely on future appreciation and reinvested earnings; with no current profit, there is little to reinvest. Graham would say the price gives no margin of safety. The Piotroski score of 4 out of 9 indicates weak fundamentals, consistent with deteriorating profitability. A small market cap amplifies the risk, and with promoter holding unavailable, I cannot judge alignment. This is a possible turnaround, but a turnaround is only an attractive investment when the price is low and the balance sheet is strong. Here the shares have risen to the top of their 52-week range despite the collapse in profit. I need evidence of a permanent fix, not hope. Until net profit returns and ROE improves meaningfully, I will keep my money in cash or in businesses I understand with demonstrable earning power.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer